Computer‐aided process analysis and economic evaluation for biosynthetic human insulin production—A case study
- 5 December 1995
- journal article
- processes
- Published by Wiley in Biotechnology & Bioengineering
- Vol. 48 (5), 529-541
- https://doi.org/10.1002/bit.260480516
Abstract
Human insulin was the first mammalian protein produced in bacteria using recombinant DNA technology. Two technologies were developed; the first based on the separate expression of precursors of chains A and B of insulin, and the second based on the expression of a precursor of proinsulin as a Trp-E fusion protein. Both technologies utilized Escherichia coli as an expression system. Later, a third technology was developed based on a strain of yeast that can secrete a precursor of insulin. The second E. coli process, a variation of which has been commercialized by Eli Lilly and Co., is analyzed in this article from a process design and economic evaluation viewpoint. The objective of this work is to elucidate the technical complexity and high cost associated with the manufacturing of biopharmaceuticals. Human insulin is a good example of a protein-based biopharmaceutical produced in large quantities (a fex tons per year) that requires large scale equipment and presents a multitude of scale-up challenges. Based onthe analysis, a number of conclusions are drawn regarding the cost breakdown and cost dependency on process parameters. Recommendations are made for cost reduction and environmental impact minimization. This analysis was performed using a software tool for computer-aided bioprocess design. © 1995 John Wiley & Sons, Inc.Keywords
This publication has 6 references indexed in Scilit:
- BioPro designer: an advanced computing environment for modeling and design of integrated biochemical processesComputers & Chemical Engineering, 1994
- Computer-Aided Design of Integrated Biochemical ProcessPublished by Springer Science and Business Media LLC ,1994
- Recombinant Human InsulinBiotechnology Progress, 1992
- New Drugs Under Development for DiabetesChemical & Engineering News, 1991
- Production scale purification of biosynthetic human insulin by reversed-phase high-performance liquid chromatographyJournal of Chromatography A, 1989
- Commercial Production of Recombinant DNA-Derived ProductsPublished by Elsevier BV ,1983